Welsh investment in Ocelus drug-delivery

A company developing a rapid and pain-free way of delivering drugs without a needle has secured investment totalling GBP100,000 ($140,860)  from Finance Wales plc and the Welsh Assembly government. Ocelus, based  in Cardiff,Wales, has developed a unique alternative to the delivery of  drugs usually given by injections with a device that pushes drugs  through the skin via microscopic particles. It has the potential to  create substantial savings for drugmakers and health services as well as  making it easier for patients to take certain drugs.

Patients or medical staff would place the device on to the skin to  deliver the compound. Taking drugs for hormone imbalances and diabetes,  cancer pain and many other treatments, including vaccines could,  potentially, be made through the new delivery system which would reduce  the pain and inconvenience of an injection.

Finance Wales plc has taken a GBP50,000 equity stake in Ocelus Ltd, with  the Welsh Assembly government providing GBP50,000 through its Single  Investment Fund to support the development and commercialization of the  product.